Blog | Grants

 

Accelerate development and/or commercialisation of your medical technology innovations with $ 800,000 of funding over a 1 year period

 

The Australian Government’s $45 million BioMedTech Horizons program is an initiative to support innovative collaborative health technologies, drive discoveries towards proof-of-concept and commercialisation that address key health challenges as well as maximise entrepreneurship and idea potential

 

Overview

BMTH Round Four Expressions Of Interest Is Now Open

Delivered by MTPConnect, the Australian Government’s $45 million BioMedTech Horizons program, is an Medical Research Future Fund (MRFF) initiative to support innovative collaborative health technologies, drive discoveries towards proof-of-concept and commercialisation that address key health challenges as well as maximise entrepreneurship and idea potential

BioMedTech Horizons Round 4 (BMTH4) is the fourth competitive funding round to be offered under the BMTH Program

MTPConnect will open a call for Expressions of Interest (EOI) to identify and select initiatives that meet all the following objectives:

  • Research to achieve the goal of using the device in the intended environment in the project period.
  • Sees the production of prototypes in Australia of a regulated medical device at a minimum classification of Class IIa as per TGA guidelines in any therapeutic area.

For the purposes of this funding opportunity a medical device is one that is used for humans and is intended to diagnose, prevent, monitor, treat or alleviate a disease or injury, or modify or monitor anatomy or physiological functions of the body, and that does not achieve its principal intended action in or on the human body by pharmacological, immunological or metabolic means, but that may be assisted in its function by such means.

 

Outline

The specific intention of BMTH4 is to support the development of the Australian medical device sector by supporting critical research and to create opportunities to locally manufacture precommercial prototypes of Australian based medical devices that are entering human clinical trials

Key details of BMTH4:

  • Four partnership opportunities of $800K each will be available.
  • Lead applicants are required to provide a minimum of 1:1 matched cash co-contribution.
  • Project activities must be completed in a maximum project term of 12 months.
  • The lead applicant must be an Australian based SME and must control or have the legal right to access and use the patent(s), trademarks or other IP necessary to undertake the proposed activities.
  • There is no specific disease focus area, however the applicant will be expected to demonstrate how, through the usage of their device, the health and wellbeing of Australians will be improved with the potential to reduce the disease burden
  • The medical device to be developed will be a physical device that is a smart monitoring device, diagnostic, personalised implant or a bionics device with a minimum classification of Class IIa as per TGA guidelines.

It is expected that:

  • Medical device prototypes to be developed and tested will be at least entering Technology Readiness Level (TRL) 5 (Prototype tested in intended environment) and mature one or two levels through the course of the project.
  • Prototype devices to be developed will be manufactured in Australia.
  • Upon completion of the project activities the prototype device will have been used in its intended environment.

 

Level of support

Four funding opportunities of $800,000 each (excluding GST) will be available to help eligible organisations advance their medical device technology toward commercialisation by supporting Australian-based pre-commercial prototype development and testing.

Funded projects must have a completion date of no later than 30 September 2022.

This program requires a minimum 1:1 matching cash contribution provided by the lead applicant.

 

Eligible activities

Proposals that deliver outcomes aligned with other national initiatives such as the Modern Manufacturing Initiative and the Medical Products Roadmap are encouraged.

Proposals that deliver outcomes aligned with other national initiatives such as the Modern Manufacturing Initiative and the Medical Products Roadmap are encouraged.

For BMTH4 the Innovation Maturity Level (IML) is to be used as a reference

They are developed by CIMIT and are designed for medical technology innovations (see Guidelines document Appendix A, below).

 

Eligible small business applicants

The Lead Applicant cannot be a University or Medical Research Institute. The lead applicant will be a medical device company developing a device and must control or have the legal right to access and use the patent(s), trademarks or other IP that will be necessary to undertake the proposed activities and to translate, implement or commercialise their product(s)/solution(s). Partner organisations can include universities

 

Lead Applicant Eligibility

For a proposal to be eligible the following requirements for the lead applicant must be met:

The lead applicant must be an:

  • Australian based business registered before 1 January 2021
    • be incorporated in Australia
    • have an ABN
    • have fewer than 200 staff
    • have group sales of less than $50M in the last fiscal year
    • the Lead Applicant cannot be a University or Medical Research Institute.
  • The lead applicant will be a medical device company developing a device and must control or have the legal right to access and use the patent(s), trademarks or other IP that will be necessary to undertake the proposed activities and to translate, implement or commercialise their product(s)/solution(s).
  • Meet the requirements demonstrating cash co-contribution outlined in Matched Funding Eligibility (below).
  • Meet any applicable application deadlines, timing, formatting, system or other similar administrative requirements imposed by MTPConnect.

 

Important dates

The application process will be conducted in a two-stage process:

Stage 1 – expression of interest (EOI) – 19 April 2021 at 5pm AEST: EOI portal closes

Stage 2 – invitation-only full application

The list of key dates is included in the BMTH4 Guidelines

The most meritorious EOIs will be invited to submit a full application. Unsuccessful EOIs will receive feedback from MTPConnect on areas where the EOI was less competitive

EOIs and full applications will be reviewed by an assessment panel comprised of MTPConnect, research, industry, and investment experts

 

How to apply

First carefully read the Guidelines for further information about eligibility and the application process

Lodge an EOI through SmartyGrants portal.

 

Getting help

Dowling Consultancy welcomes enquiries from small businesses requiring professional grant application and submission guidance to enhance their chances of success. We have assisted numerous businesses with grant applications that win government grants. Contact Steve Dowling on 0409 478 850 for a confidential, no obligation discussion

We helped Bionic Vision Technologies be awarded a $ 1 million grant in round 3.0

 

Learn more